Pelham Capital Ltd. Grifols Sa Transaction History

Pelham Capital Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 23, 2020	SELL	$15.4 - $20.16 $3.6 Million - $4.71 Million	-233,814 Closed	0 $0
Q2 2020 Jul 24, 2020	SELL	$18.24 - $21.45 $7.91 Million - $9.31 Million	-433,921 Reduced 64.98%	233,814 $4.27 Million
Q1 2020 Apr 22, 2020	BUY	$16.28 - $25.63 $10.9 Million - $17.1 Million	667,735 New	667,735 $13.4 Million

147

151M

2.38M

662K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $6.08B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Pelham Capital Ltd., based on Form 13F filings with the SEC.

Stay updated on Pelham Capital Ltd. with notifications on news.